Wang Xiaofei, Song Xudong, Cheng Guang, Zhang Jingwen, Dong Liru, Bai Jie, Luo Dan, Xiong Yanjie, Li Shuang, Liu Fang, Sun Yuanyuan, Wang Xin, Li Yuyang, Huang Yunning
Department of Pathology, North China University of Science and Technology Affiliated Hospital, Tangshan 063000, Hebei, People's Republic of China.
Central Laboratory of Clinical Medical College, North China University of Science and Technology Affiliated Hospital, Tangshan 063000, Hebei, People's Republic of China.
Onco Targets Ther. 2020 Nov 17;13:11781-11794. doi: 10.2147/OTT.S262049. eCollection 2020.
Increasing evidences suggest that mitochondrial calcium uniporter (MCU), a selective channel responsible for mitochondrial Ca uptake, is involved in the progression of several cancers. In this study, we aimed to observe the clinical implications and biological functions of MCU in gastric cancer.
The expression of MCU in 90 pairs of gastric cancer tissues and adjacent normal tissues was examined using immunohistochemistry and correlation between MCU expression and clinical features was analyzed. After construction of stable MCU knockdown or overexpression gastric cancer cells, mitochondrial membrane potential (MMP), wound healing and transwell assays were performed to examine MMP levels, migration and invasion. Subcutaneous xenograft tumors induced by gastric cancer cells transfected with MCU siRNAs or controls were constructed. Immunofluorescence was used to detect CD34 expression. Western blot was used to detect the expression of hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF), epithelial-mesenchymal transition (EMT)-related proteins.
MCU had a higher expression in gastric cancer tissues than normal tissues. Compared to gastric cancer tissues, its expression was significantly higher after omental metastasis. MCU expression was significantly correlated with depth of invasion (p=0.048), lymph metastasis (p=0.027), TNM stage (p=0.036) and distant metastasis (p=0.029). Patients with high MCU expression indicated a worse prognosis than those with its low expression (p=0.0098). MCU significantly increased the MMP levels of gastric cancer cells. Wound healing and transwell assay results showed that MCU promoted migration and invasion of gastric cancer cells. In vivo, MCU knockdown significantly inhibited tumor growth and angiogenesis. Both in vitro and in vivo, silencing MCU suppressed the expression of HIF-1α and VEGF as well as activity of EMT processes.
Our findings suggested that highly expressed MCU could promote migration, invasion, angiogenesis and growth of gastric cancer, which could become a potential therapeutic marker for gastric cancer.
越来越多的证据表明,线粒体钙单向转运体(MCU)是一种负责线粒体钙摄取的选择性通道,参与多种癌症的进展。在本研究中,我们旨在观察MCU在胃癌中的临床意义和生物学功能。
采用免疫组织化学检测90对胃癌组织及癌旁正常组织中MCU的表达,并分析MCU表达与临床特征之间的相关性。构建稳定敲低或过表达MCU的胃癌细胞后,进行线粒体膜电位(MMP)、伤口愈合和Transwell实验,以检测MMP水平、迁移和侵袭能力。构建用MCU siRNA或对照转染的胃癌细胞诱导的皮下异种移植瘤。采用免疫荧光检测CD34表达。用蛋白质免疫印迹法检测缺氧诱导因子-1α(HIF-1α)、血管内皮生长因子(VEGF)、上皮-间质转化(EMT)相关蛋白的表达。
MCU在胃癌组织中的表达高于正常组织。与胃癌组织相比,大网膜转移后其表达显著升高。MCU表达与浸润深度(p=0.048)、淋巴结转移(p=0.027)、TNM分期(p=0.036)和远处转移(p=0.029)显著相关。MCU高表达患者的预后比低表达患者差(p=0.0098)。MCU显著提高胃癌细胞的MMP水平。伤口愈合和Transwell实验结果表明,MCU促进胃癌细胞的迁移和侵袭。在体内,敲低MCU显著抑制肿瘤生长和血管生成。在体外和体内,沉默MCU均抑制HIF-1α和VEGF的表达以及EMT过程的活性。
我们的研究结果表明,高表达的MCU可促进胃癌的迁移、侵袭、血管生成和生长,这可能成为胃癌潜在的治疗标志物。